DPT Enhances Capabilities at its San Antonio Center of Excellence
News Oct 31, 2014
DPT Laboratories has announced the implementation of a high-speed bottle filling center at its San Antonio location.
One of three DPT Centers of Excellence, the San Antonio location is purpose-built for semi-solids and liquids to support comprehensive pharmaceutical manufacturing needs. The new high-speed bottle filling center provides large-scale production capacity, and maximizes efficiency.
“We’re committed to investing in new capabilities and expanding services for our customers,” said Lyle Flom, Vice President and General Manager, San Antonio Site Operations.
“The addition of this high-speed filling center supports current demand, provides for future growth and helps DPT maintain its leadership position in semi-solid and liquid manufacturing.”
The new line significantly increases the rate of production for finished goods bottle manufacturing - up to 200 units per minute - and creates opportunities for growth in its large scale bulk manufacturing areas. With increased throughput capability, DPT now has the opportunity to provide bright stock supply chain services to clients seeking an external solution to their private label manufacturing needs.
“Our regulatory and customer service track record speaks to our ability to effectively deliver our customer’s production needs today. This high-speed filling center will enhance that ability for years to come,” said Flom.
As DPT’s Center of Excellence for Semi-solids and Liquids, the San Antonio location provides cGMP pilot, clinical and commercial scale manufacturing for prescription and over-the-counter products.
It includes a 60,000-square-foot cGMP aerosol manufacturing facility, a 225,000-square-foot raw material dispensing and distribution center and a 150,000-square-foot compounding, fill and finish area.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Alzheimer’s Drug Discovery Foundation Announces $1.8M in New FundingNews
The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.READ MORE
New Research Hub to Tackle Global Vaccination ChallengesNews
The University of Bristol will contribute to a new research hub to increase global immunisation coverage and improve response to viral outbreaks through the rapid and cost-effective deployment of vaccines.READ MORE